WITHDRAWAL OF LOW-DOSE STEROIDS IN SYSTEMIC LUPUS ERYTHEMATOSUS IN REMISSION: PREDICTORS OF FLARES AND DIFFERENCE IN OUTCOMES IN SEROLOGICALLY ACTIVE CLINICALLY QUIESCENT PATIENTS

被引：2
|
作者：
Fasano, S. [1 ]
Pierro, L. [1 ]
Coscia, M. A. [1 ]
Bucci, L. [1 ]
Scriffignano, S. [1 ]
Riccardi, A. [1 ]
Ciccia, F. [1 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Rheumatol, Naples, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
CLASSIFICATION;
D O I：
10.1136/annrheumdis-2020-eular.1691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0162
引用
下载
收藏
页码：1017 / 1018
页数：2
相关论文
共 50 条
  • [21] Prolonged Serologically Active Clinically Quiescent (SACQ) Systemic Lupus Erythematosus (SLE): Clinical and Serologic Features
    Steiman, Amanda
    Gladman, Dafna
    Ibanez, Dominique
    Urowitz, Murray
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1346 - 1346
  • [22] SEROLOGICALLY ACTIVE CLINICALLY QUIESCENT SYSTEMIC LUPUS-ERYTHEMATOSUS - DISCORDANCE BETWEEN CLINICAL AND SEROLOGIC FEATURES
    GLADMAN, DD
    UROWITZ, MB
    KEYSTONE, EC
    AMERICAN JOURNAL OF MEDICINE, 1979, 66 (02): : 210 - 215
  • [23] RISK OF FLARE AND DAMAGE ACCRUAL AFTER TAPERING GLUCOCORTICOIDS IN SEROLOGICALLY ACTIVE CLINICALLY QUIESCENT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Katsumata, Y.
    Inoue, E.
    Harigai, M.
    Kandane-Rathnayake, R.
    Louthrenoo, W.
    Hoi, A.
    Golder, V.
    Lau, C. S.
    Cho, J.
    Lateef, A.
    Chen, Y. H.
    Luo, S. F.
    Wu, Y. J. Jan
    Hamijoyo, L.
    Li, Z.
    Sockalingam, S.
    Navarra, S.
    Zamora, L.
    Hao, Y.
    Zhang, Z.
    Chan, M.
    Oon, S.
    Ng, K.
    Kikuchi, J.
    Takeuchi, T.
    Goldblatt, F.
    O'neill, S.
    Tugnet, N.
    Law, A.
    Bae, S. C.
    Tanaka, Y.
    Ohkubo, N.
    Kumar, S.
    Nikpour, M.
    Morand, E. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 31 - 32
  • [24] Follow-up and management of serologically active clinically quiescent cases in pediatric systemic lupus erythematosus
    Capone, Gabrielle
    Lojacono, Caroline
    Al-Bayitee, Fatma
    Makvandi, Shayan
    Hennon, Teresa
    Wrotniak, Brian
    Abdul-Aziz, Rabheh
    REUMATOLOGIA, 2021, 59 (04): : 244 - 251
  • [25] Association of anti-nucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus
    Ng, K. P.
    Manson, J. J.
    Rahman, A.
    Isenberg, D. A.
    RHEUMATOLOGY, 2006, 45 : I164 - I165
  • [26] Interferon-Associated Cytokine and Chemokine Expression in Patients with Serologically Active Clinically Quiescent (SACQ) Systemic Lupus Erythematosus (SLE)
    Steiman, Amanda J.
    Urowitz, Murray B.
    Ibanez, Domi-Nique
    Landolt-Marticorena, Carolina
    Gladman, Dafna D.
    Wither, Joan E.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1137 - S1138
  • [27] Interferon-associated Cytokine and Chemokine Expression in Patients with Serologically Active Clinically Quiescent (SACQ) Systemic Lupus Erythematosus (SLE)
    Steiman, Amanda
    Urowitz, Murray
    Ibanez, Dominique
    Landolt-Marticorena, Carolina
    Gladman, Dafna
    Wither, Joan
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 954 - 955
  • [28] SEROLOGICALLY ACTIVE, CLINICALLY QUIESCENT SYSTEMIC LUPUS-ERYTHEMATOSUS - LONG-TERM FOLLOW-UP
    LEBLANC, BAEW
    UROWITZ, MB
    GLADMAN, DD
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (01) : 174 - 175
  • [29] THE IMPACT OF HYDROXYCHLOROQUINE DAILY DOSE IN THE PREVENTION OF FLARES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN REMISSION
    Fasano, S.
    Messiniti, V.
    Coscia, M. A.
    Gaggiano, E.
    Iudici, M.
    Ciccia, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1165 - 1166
  • [30] No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study
    Ayano, Masahiro
    Hirata, Akie
    Tokunaga, Shoji
    Furuhashi, Hiroko
    Kimoto, Yasutaka
    Ono, Nobuyuki
    Arinobu, Yojiro
    Nakashima, Naoki
    Akashi, Koichi
    Horiuchi, Takahiko
    Niiro, Hiroaki
    RHEUMATOLOGY INTERNATIONAL, 2024, : 2411 - 2419
12345